Join Andelyn’s Newsletter: Your Source for Quality Insights on Cell and Gene Therapies
Subscribe

Advancing Discoveries. Manufacturing Cures.

Your Trusted and Reliable Gene Therapy CDMO from Concept to Commercial Manufacturing.

75+ INDs
Approved
Multiple Decades
of Gene therapy Manufacturing
450+ cGMP
Clinical Batches
PPQs
Material Generated Supporting BLA
250k
Combined Square Feet of Facility Space

Partner with us for the advancement of life-altering genetic therapies for patients, and for shaping a healthier world.

Substantiated by decades of pioneering research, closeness to patients, and the production of over 450 GMP batches of viral vector therapies for rare diseases, along with the origin of a currently approved gene therapy, Andelyn Biosciences is a proven and reliable full-service cell and gene therapy CDMO with deep scientific and manufacturing expertise and a track record of success.

Empowering Breakthroughs, Enhancing Lives.

A Journey of Innovation and Growth

Andelyn Biosciences is driven by its mission of accelerating the development and manufacturing of innovative therapies to bring more treatments to more patients. Our dedication to scientific excellence, collaborative partnerships, and reliable manufacturing reflects our commitment to meet the current needs of the industry and to anticipate and shape its future. Through tech transfer of established processes or the adoption of our data-driven and program-specific Optimization-By-Design™ AAV Curator™ Platform, together we strive to overcome the greatest challenges in gene therapy: enabling our partners to deliver life-changing treatments to those in need.

Our journey is a testament to our enduring commitment to advancing healthcare. Discover the milestones and achievements that have shaped our vision of Turning Hope Into Reality™.

Capabilities for Efficient and Successful Gene Therapy Programs

Andelyn Biosciences provides a full suite of services tailored to your specific program to accelerate your path from concept to commercialization. Explore how each of our specialized capabilities can contribute to your program’s success.

View Our Capabilities
Facilities

Facilities Driving Innovation and Breakthroughs

Explore the environments where innovation and quality meet. Andelyn Biosciences proudly operates three specialized facilities, each designed to support different stages of gene therapy development and manufacturing. Discover how our advanced infrastructure and strategic locations contribute to accelerating your path to market.

Discover Our Facilities

Hear from Our Partners

Success Stories
Learn More About Us
“Working with Andelyn was a great choice given their history with the product, their extensive multi-product experience with the manufacturing technology used for the product, and our desire to quickly bring UX111 to MPS IIIA patients.”
Dennis Huang
Chief Technical Operations Officer and EVP, Gene Therapy Research and Development
Ultragenyx
“Purespring is excited to build on our longstanding working relationship with Andelyn to accelerate the preclinical and clinical manufacture of our innovative AAV-based gene therapies.”
Julian Hanak
CEO
Purespring Therapeutics

Maximize Efficiency with Our Proven AAV Curator™ Platform

Unlock the potential to dramatically reduce your program costs and accelerate your timeline. See how Andelyn Biosciences' proven AAV Curator™ Platform can streamline your gene therapy development process.

Explore Our Platform
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.